Inspira Technologies Oxy B.H.N. Ltd. (IINN)
NASDAQ: IINN · Real-Time Price · USD
0.7500
-0.0300 (-3.85%)
At close: Jan 30, 2026, 4:00 PM EST
0.7452
-0.0048 (-0.64%)
After-hours: Jan 30, 2026, 6:07 PM EST
IINN Employees
As of December 31, 2024, Inspira Technologies Oxy B.H.N. had 45 total employees, including 38 full-time and 7 part-time employees. The number of employees increased by 3 or 7.14% compared to the previous year.
Employees
45
Change (1Y)
3
Growth (1Y)
7.14%
Revenue / Employee
$6,422
Profits / Employee
-$249,133
Market Cap
26.96M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 45 | 3 | 7.14% | 38 | 7 |
| Dec 31, 2023 | 42 | 5 | 13.51% | 37 | 5 |
| Dec 31, 2022 | 37 | 8 | 27.59% | 32 | 5 |
| Dec 31, 2021 | 29 | - | - | 26 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Nortech Systems | 744 |
| Myomo | 185 |
| Cytosorbents | 149 |
| Baird Medical Investment Holdings | 143 |
| IRIDEX | 93 |
| Adagio Medical Holdings | 80 |
| VolitionRx | 75 |
| Pulsenmore | 58 |
IINN News
- 10 days ago - Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders - GlobeNewsWire
- 26 days ago - CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation - GlobeNewsWire
- 26 days ago - Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation - GlobeNewsWire
- 5 weeks ago - Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones - GlobeNewsWire
- 6 weeks ago - Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution - GlobeNewsWire
- 2 months ago - Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology - GlobeNewsWire
- 2 months ago - Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission - GlobeNewsWire
- 3 months ago - Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion - GlobeNewsWire